Literature DB >> 3235657

Collaborative evaluation in seven laboratories of a standardized micromethod for yeast susceptibility testing.

R Guinet1, D Nerson, F de Closets, J Dupouy-Camet, L Kures, M Marjollet, J L Poirot, A Ros, J Texier-Maugein, P J Volle.   

Abstract

The new micromethod for yeast susceptibility testing, MYCOTOTAL, was evaluated with 10 reference strains in seven laboratories. Ready-to-use microtitration plates and the same synthetic medium were used with two dilutions of imidazoles, flucytosine, and amphotericin B, permitting the categorization of each strain as susceptible, intermediate, or resistant. The results were compared with the MIC for each reference strain, and the repeatability and reproducibility were evaluated. The yeasts tested presenting different patterns of susceptibilities in reference MICs included six strains of Candida albicans, two strains of Candida tropicalis, one strain of Candida parapsilosis, and one strain of Torulopsis glabrata. For 4,200 antifungal agent-yeast results, the repeatability was 99.3% and the reproducibility was 96.3%. The correlation between the reference MICs and the category results was 91.5% for seven laboratories (and 92.7% for six laboratories excluding the laboratory which did not follow exactly the same protocol). We observed only 7.9% minor discrepancies, 0.5% (0.29% for six laboratories) major discrepancies, and 0.1% uninterpretable results. The percentages of concording results were similar for each strain and each antifungal agent tested. The overall results indicated that MYCOTOTAL was a reliable and reproducible method, well correlated with reference MICs. This ready-to-use micromethod with the same medium for all antifungal agents would be an important step in the necessary standardization of yeast susceptibility testing.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3235657      PMCID: PMC266882          DOI: 10.1128/jcm.26.11.2307-2312.1988

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  32 in total

Review 1.  In vitro antifungal susceptibility testing and measurement of levels of antifungal agents in body fluids.

Authors:  D J Drutz
Journal:  Rev Infect Dis       Date:  1987 Mar-Apr

2.  Preliminary studies on the pharmacology and therapeutic activity of oral and intravenous econazole.

Authors:  E Drouhet; B Dupont
Journal:  Mykosen Suppl       Date:  1978

3.  Improved method for estimation of azole antifungal inhibitory concentrations against Candida species, based on azole/antibiotic interactions.

Authors:  F C Odds; A B Abbott; G Pye; P F Troke
Journal:  J Med Vet Mycol       Date:  1986-08

Review 4.  Test methods for antifungal agents--a critical review.

Authors:  M Plempel; D Berg; K H Büchel; D Abbink
Journal:  Mykosen       Date:  1987-01

Review 5.  Antifungal drug susceptibility testing. A critical review.

Authors:  D A Stevens
Journal:  Mycopathologia       Date:  1984-09-30       Impact factor: 2.574

6.  Antifungal effects of fluconazole (UK 49858), a new triazole antifungal, in vitro.

Authors:  F C Odds; S L Cheesman; A B Abbott
Journal:  J Antimicrob Chemother       Date:  1986-10       Impact factor: 5.790

7.  [Comparative sensitivity of yeasts to antifungal agents using a standardized micromethod].

Authors:  R Guinet
Journal:  Pathol Biol (Paris)       Date:  1986-05

8.  Effect of medium composition on results of macrobroth dilution antifungal susceptibility testing of yeasts.

Authors:  G V Doern; T A Tubert; K Chapin; M G Rinaldi
Journal:  J Clin Microbiol       Date:  1986-10       Impact factor: 5.948

9.  New azole compounds: vibunazole (Bay n7133) and Bay L9139, compared with ketoconazole in the therapy of systemic candidosis and in pharmacokinetic studies, in mice.

Authors:  E Lefler; D A Stevens
Journal:  J Antimicrob Chemother       Date:  1985-01       Impact factor: 5.790

10.  Influence of culture medium on susceptibility testing with BAY n 7133 and ketoconazole.

Authors:  P D Hoeprich; J M Merry
Journal:  J Clin Microbiol       Date:  1986-08       Impact factor: 5.948

View more
  16 in total

Review 1.  Antifungal susceptibility testing: practical aspects and current challenges.

Authors:  J H Rex; M A Pfaller; T J Walsh; V Chaturvedi; A Espinel-Ingroff; M A Ghannoum; L L Gosey; F C Odds; M G Rinaldi; D J Sheehan; D W Warnock
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

2.  In vitro studies of activities of some antifungal agents against Candida albicans ATCC 10231 by the turbidimetric method.

Authors:  M T Blanco; C Pérez-Giraldo; J Blanco; F J Morán; C Hurtado; A C Gómez-García
Journal:  Antimicrob Agents Chemother       Date:  1992-04       Impact factor: 5.191

Review 3.  Susceptibility testing of fungi: current status of correlation of in vitro data with clinical outcome.

Authors:  M A Ghannoum; J H Rex; J N Galgiani
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

Review 4.  Testing of organisms for susceptibility to triazoles: is it justified?

Authors:  G S Kobayashi; E D Spitzer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-05       Impact factor: 3.267

Review 5.  Antifungal susceptibility testing.

Authors:  J H Rex; M A Pfaller; M G Rinaldi; A Polak; J N Galgiani
Journal:  Clin Microbiol Rev       Date:  1993-10       Impact factor: 26.132

6.  A new method of antibiotyping yeasts for subspecies discrimination and distribution in human clinical specimens.

Authors:  G Quindós; V Lipperheide; B Barturen; R Alonso; J Bikandi; R San Millán; M Tellaetxe; L Ribacoba; J Pontón
Journal:  Eur J Epidemiol       Date:  1996-02       Impact factor: 8.082

7.  Mycotic keratitis due to Aspergillus nomius.

Authors:  Palanisamy Manikandan; János Varga; Sándor Kocsubé; Robert A Samson; Raghavan Anita; Rajaraman Revathi; Ilona Dóczi; Tibor Mihály Németh; Venkatapathy Narendran; Csaba Vágvölgyi; Chockaiya Manoharan; László Kredics
Journal:  J Clin Microbiol       Date:  2009-08-26       Impact factor: 5.948

8.  Antagonistic effects of fluconazole and 5-fluorocytosine on candidacidal action of amphotericin B in human serum.

Authors:  E Martin; F Maier; S Bhakdi
Journal:  Antimicrob Agents Chemother       Date:  1994-06       Impact factor: 5.191

9.  In vitro activity of cloconazole, sulconazole, butoconazole, isoconazole, fenticonazole, and five other antifungal agents against clinical isolates of Candida albicans and Candida spp.

Authors:  J M Hernández Molina; J Llosá; A Martinez Brocal; A Ventosa
Journal:  Mycopathologia       Date:  1992-04       Impact factor: 2.574

10.  Multicenter evaluation of a broth macrodilution antifungal susceptibility test for yeasts.

Authors:  R A Fromtling; J N Galgiani; M A Pfaller; A Espinel-Ingroff; K F Bartizal; M S Bartlett; B A Body; C Frey; G Hall; G D Roberts
Journal:  Antimicrob Agents Chemother       Date:  1993-01       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.